RxDoctor Payments Data

Skyler Buck, PA

Physician Assistant · Saint George, UTNPI 1033671193

Payments from drug & device makers

$1,710in general payments, 2019–2025

Across 71 payments — averaging $24.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$665
  • Abbott$352
  • Boston Scientific$259
  • Pfizer$124
  • Johnson & Johnson$84
  • Atricure, Inc.$70
  • plus $154 from 4 others

What the payments were for

  • Food & beverage$1,65397%
  • Education$573%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,710 in reported general payments places this provider in the 80th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$54,944
Medicare patients
436
Services billed
670

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban328$402,320
XareltoRivaroxaban141$193,858
Metoprolol Succinate264$3,843
Amiodarone Hcl222$3,677
SotalolSotalol Hcl128$3,140
Dofetilide19$2,682
Flecainide Acetate48$2,236
Diltiazem 24hr Er (Cd)Diltiazem Hcl37$1,322
Metoprolol Tartrate105$661
Propranolol Hcl23$491
Diltiazem Hcl22$407
Digoxin16$387
Potassium Chloride11$356
Warfarin Sodium35$307
Carvedilol25$206

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$124$402,320328 claims
Johnson & JohnsonXarelto$84$193,858141 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Saint George

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →